213 related articles for article (PubMed ID: 25051441)
1. GLP-1 analog liraglutide enhances proinsulin processing in pancreatic β-cells via a PKA-dependent pathway.
Wang L; Liu Y; Yang J; Zhao H; Ke J; Tian Q; Zhang L; Wen J; Wei R; Hong T
Endocrinology; 2014 Oct; 155(10):3817-28. PubMed ID: 25051441
[TBL] [Abstract][Full Text] [Related]
2. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ
J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of ERp46 under diabetic conditions in β-cells and the effect of liraglutide.
Lampropoulou E; Lymperopoulou A; Charonis A
Metabolism; 2016 Jan; 65(1):7-15. PubMed ID: 26683792
[TBL] [Abstract][Full Text] [Related]
4. Estimated proinsulin processing activity of prohormone convertase (PC) 1/3 rather than PC2 is decreased in pancreatic β-cells of type 2 diabetic patients.
Ozawa S; Katsuta H; Suzuki K; Takahashi K; Tanaka T; Sumitani Y; Nishida S; Yoshimoto K; Ishida H
Endocr J; 2014; 61(6):607-14. PubMed ID: 24705588
[TBL] [Abstract][Full Text] [Related]
5. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide regulates the viability of pancreatic α-cells and pancreatic β-cells through cAMP-PKA signal pathway.
Xu X; Chen J; Hu L; Liang M; Wang X; Feng S; Shen J; Luan X
Life Sci; 2018 Feb; 195():87-94. PubMed ID: 29225111
[TBL] [Abstract][Full Text] [Related]
7. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
[TBL] [Abstract][Full Text] [Related]
8. Proinsulin maturation disorder is a contributor to the defect of subsequent conversion to insulin in β-cells.
Wang J; Osei K
Biochem Biophys Res Commun; 2011 Jul; 411(1):150-5. PubMed ID: 21723250
[TBL] [Abstract][Full Text] [Related]
9. Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats.
Nie Y; Nakashima M; Brubaker PL; Li QL; Perfetti R; Jansen E; Zambre Y; Pipeleers D; Friedman TC
J Clin Invest; 2000 Apr; 105(7):955-65. PubMed ID: 10749575
[TBL] [Abstract][Full Text] [Related]
10. Revisiting Proinsulin Processing: Evidence That Human β-Cells Process Proinsulin With Prohormone Convertase (PC) 1/3 but Not PC2.
Ramzy A; Asadi A; Kieffer TJ
Diabetes; 2020 Jul; 69(7):1451-1462. PubMed ID: 32291281
[TBL] [Abstract][Full Text] [Related]
11. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
Whalley NM; Pritchard LE; Smith DM; White A
J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line.
Akiyama S; Ogiwara T; Aoki T; Tsunekawa K; Araki O; Murakami M
Life Sci; 2014 Oct; 115(1-2):22-8. PubMed ID: 25241124
[TBL] [Abstract][Full Text] [Related]
14. Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets.
Huang C; Yuan L; Cao S
Int J Mol Med; 2015 Jul; 36(1):173-85. PubMed ID: 25976560
[TBL] [Abstract][Full Text] [Related]
15. Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3.
Zhu X; Orci L; Carroll R; Norrbom C; Ravazzola M; Steiner DF
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10299-304. PubMed ID: 12136131
[TBL] [Abstract][Full Text] [Related]
16. Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6.
Furukawa H; Carroll RJ; Swift HH; Steiner DF
Diabetes; 1999 Jul; 48(7):1395-401. PubMed ID: 10389844
[TBL] [Abstract][Full Text] [Related]
17. The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice.
Fosgerau K; Jessen L; Lind Tolborg J; Østerlund T; Schæffer Larsen K; Rolsted K; Brorson M; Jelsing J; Skovlund Ryge Neerup T
Diabetes Obes Metab; 2013 Jan; 15(1):62-71. PubMed ID: 22862961
[TBL] [Abstract][Full Text] [Related]
18. Pax6 directly down-regulates Pcsk1n expression thereby regulating PC1/3 dependent proinsulin processing.
Liu T; Zhao Y; Tang N; Feng R; Yang X; Lu N; Wen J; Li L
PLoS One; 2012; 7(10):e46934. PubMed ID: 23056534
[TBL] [Abstract][Full Text] [Related]
19. Protective action of liraglutide in beta cells under lipotoxic stress via PI3K/Akt/FoxO1 pathway.
Shao S; Nie M; Chen C; Chen X; Zhang M; Yuan G; Yu X; Yang Y
J Cell Biochem; 2014 Jun; 115(6):1166-75. PubMed ID: 24415347
[TBL] [Abstract][Full Text] [Related]
20. A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model.
Gaspari T; Liu H; Welungoda I; Hu Y; Widdop RE; Knudsen LB; Simpson RW; Dear AE
Diab Vasc Dis Res; 2011 Apr; 8(2):117-24. PubMed ID: 21562063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
